News

A healthcare giant. One of only 30 stocks in the Dow Jones Industrial Average. A longtime investors' favorite. UnitedHealth Group (NYSE: UNH) is all those things. However, it's also now a big loser.

During the month of May, stocks started exhibiting some much-needed resilience. The S&P 500 and Nasdaq Composite indexes rose by 5% and 8%, respectively.

After bearing the brunt of precipitous

In this video, I will cover the recent updates regarding UnitedHealth (NYSE: UNH). Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock prices

Buying stocks of companies benefiting from long-term industry trends can help you identify rewarding investment opportunities. The following companies are serving growing demand in the semiconductor

If you have an opening in your portfolio for a great stock with solid growth potential and perhaps even a respectable dividend yield, you would do well to give Pfizer (NYSE: PFE) some serious

There is a ton of money in America's healthcare system. The country's annual healthcare expenditures push $5 trillion, representing nearly a fifth of the world's largest economy. UnitedHealth (NYSE:

When broader equities are volatile, it's tempting to focus on what's going to happen in the near term. That's why some investors resort to panic selling -- they anticipate that things will get even

The stock market has seen a sharp rebound after the declines in the first quarter, so valuations are not as cheap as they once were. However, I am constantly searching for undervalued stocks.

In

President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of

Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors might prefer to do their own research

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also provides

UnitedHealth (NYSE: UNH) is struggling to recover investor trust that was eroded when the company missed its earnings expectations.

*Stock prices used were the afternoon prices of June 2, 2025. The

Investors are always looking for smart money managers to get ideas from. One investor I like to follow is David Tepper, the billionaire founder of Appaloosa Management. And, fortunately, I can get

UnitedHealth Group (NYSE: UNH) stock has been in a free fall due to a flurry of bad news. Heading into trading this week, shares of the health insurer had crashed more than 40% thus far in 2025

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more

Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after

HealthEquity (NASDAQ:HQY) reported fiscal 2026 first quarter (ended April 30, 2025) earnings on June 3, 2025, delivering 15% year-over-year revenue growth and raising full-year guidance. Key

Cathie Wood is rolling again. Growth stocks are back in favor, and that's good news for the founder, CEO, and primary investment manager of the Ark Invest family of exchange-traded funds (ETFs).

U.S. Rep. Marjorie Taylor Greene, a Georgia Republican, recently disclosed some buys in red-hot artificial intelligence (AI) stock Palantir Technologies (NASDAQ: PLTR), according to data compiled by

It took 13 years, 15 nations, and roughly $100 billion to build the International Space Station (ISS). But one company thinks it can build a replacement for as little as $3 billion -- or less.

That

On a generally upbeat Monday for the stock market, investors weren't only buying into U.S. companies. Quite a few of them also piled into the American Depositary Receipts (ADRs) of Danish biotech Ge